Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Schmoll

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Langenbecks Archiv Fur Chirurgie|January 1, 1997
[Intraoperative (hyperthermic) intraperitoneal chemotherapy--considerations and aspects of safe intra- and postoperative treatment with cytostatic drugs]J Jähne, P Piso, E Schmoll, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastasesJ T Hartmann, E Schmoll, C Bokemeyer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinomaC Bokemeyer, B Kynast, A Harstrick, et al.
Deutsche Medizinische Wochenschrift (1946)|January 27, 1989
[Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin]B Bokemeyer, R Grote, E Schmoll, et al.
Surgery|June 17, 1998
First experience and technical aspects of isolated liver perfusion for extensive liver metastasisK J Oldhafer, H Lang, M Frerker, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumoursC Schöber, E Schmoll, H J Schmoll, et al.
Seminars in Oncology|April 1, 1991
Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II studyM Stahl, E Schmoll, H Becker, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 23, 1999
High-dose mitomycin C in isolated hyperthermic liver perfusion for unresectable liver metastasesK J Oldhafer, M K Frerker, H Lang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Anti-idiotype immunization of cancer patients: modulation of the immune responseD Herlyn, M Wettendorff, E Schmoll, et al.
Der Radiologe|February 1, 1992
[Chemoembolization of hepatocellular carcinoma in cases of isolated liver involvement]M Galanski, E Schmoll, S Reichelt, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Langenbecks Archiv Fur Chirurgie|January 1, 1997
[Intraoperative (hyperthermic) intraperitoneal chemotherapy--considerations and aspects of safe intra- and postoperative treatment with cytostatic drugs]J Jähne, P Piso, E Schmoll, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastasesJ T Hartmann, E Schmoll, C Bokemeyer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
No synergistic activity of epirubicin and interferon-alpha 2b in the treatment of hepatocellular carcinomaC Bokemeyer, B Kynast, A Harstrick, et al.
Deutsche Medizinische Wochenschrift (1946)|January 27, 1989
[Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin]B Bokemeyer, R Grote, E Schmoll, et al.
Surgery|June 17, 1998
First experience and technical aspects of isolated liver perfusion for extensive liver metastasisK J Oldhafer, H Lang, M Frerker, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumoursC Schöber, E Schmoll, H J Schmoll, et al.
Seminars in Oncology|April 1, 1991
Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II studyM Stahl, E Schmoll, H Becker, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 23, 1999
High-dose mitomycin C in isolated hyperthermic liver perfusion for unresectable liver metastasesK J Oldhafer, M K Frerker, H Lang, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Anti-idiotype immunization of cancer patients: modulation of the immune responseD Herlyn, M Wettendorff, E Schmoll, et al.
Der Radiologe|February 1, 1992
[Chemoembolization of hepatocellular carcinoma in cases of isolated liver involvement]M Galanski, E Schmoll, S Reichelt, et al.
Pageof 3